Cargando…
In Silico and In Vitro Study of Janus Kinases Inhibitors from Naphthoquinones
Janus kinases (JAKs) are involved in numerous cellular signaling processes related to immune cell functions. JAK2 and JAK3 are associated with the pathogenesis of leukemia and common lymphoid-derived illnesses. JAK2/3 inhibitors could reduce the risk of various diseases by targeting this pathway. He...
Autores principales: | Sanachai, Kamonpan, Mahalapbutr, Panupong, Tabtimmai, Lueacha, Seetaha, Supaphorn, Kaekratoke, Nantawat, Chamni, Supakarn, Azam, Syed Sikander, Choowongkomon, Kiattawee, Rungrotmongkol, Thanyada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866339/ https://www.ncbi.nlm.nih.gov/pubmed/36677654 http://dx.doi.org/10.3390/molecules28020597 |
Ejemplares similares
-
Discovery of JAK2/3
Inhibitors from Quinoxalinone-Containing
Compounds
por: Sanachai, Kamonpan, et al.
Publicado: (2022) -
Pharmacophore-Based
Virtual Screening and Experimental
Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases
por: Sanachai, Kamonpan, et al.
Publicado: (2022) -
Identification of Vinyl Sulfone Derivatives as EGFR Tyrosine Kinase Inhibitor: In Vitro and In Silico Studies
por: Aiebchun, Thitinan, et al.
Publicado: (2021) -
Insights into the Binding Recognition and Susceptibility
of Tofacitinib toward Janus Kinases
por: Sanachai, Kamonpan, et al.
Publicado: (2020) -
Biological Evaluation and Molecular Dynamics Simulation of Chalcone Derivatives as Epidermal Growth Factor-Tyrosine Kinase Inhibitors
por: Sangpheak, Kanyani, et al.
Publicado: (2019)